{{Rsnum
|rsid=11650680
|Chromosome=17
|position=40422984
|Orientation=plus
|GMAF=0.1676
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 55.8 | 39.8 | 4.4
| HCB | 62.0 | 32.1 | 5.8
| JPT | 75.2 | 23.0 | 1.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 62.0 | 32.1 | 5.8
| CHD | 59.6 | 33.0 | 7.3
| GIH | 68.3 | 27.7 | 4.0
| LWK | 96.4 | 3.6 | 0.0
| MEX | 51.7 | 46.6 | 1.7
| MKK | 92.9 | 6.4 | 0.6
| TSI | 65.7 | 32.4 | 2.0
| HapMapRevision=28
}}
{{PMID|19175592}} [[Asthma]] diagnosis was associated with rs11650680 and five other SNPs including [[rs7216389]] (P = 0.019-0.034)

{{PMID Auto
|PMID=22370936
|Title=Genetic variants on 17q21 are associated with asthma  in a Han Chinese population
}}

{{PMID Auto
|PMID=18310477
|Title=ORMDL3 gene is associated with asthma in three ethnically diverse populations.
|OA=1
}}

{{PMID Auto
|PMID=22626592
|Title=17q12-21 variants are associated with asthma and interact with active smoking in an adult population from the United Kingdom.
}}

{{PMID Auto
|PMID=22732088
|Title=GSDMB/ORMDL3 variants contribute to asthma susceptibility and eosinophil-mediated bronchial hyperresponsiveness.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}